1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BAUSCH HEALTH COMPANIES INC

Bausch Health Companies Inc

XNYS: BHC

Download real time

7.16 0.03 (0.42%)

37.52% Fall from 52W High

2.5M XNYS Volume

XNYS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
11S
5W
4O
1T
2,634.4

Market Cap

High in industry
-57.3

PE TTM

Negative PE TTM
-0.6

PEG TTM

PEG TTM is negative
-2.1

Price to Book

Negative Price to Book
0.6

Beta 1Year

Very Low volatility


Insider Trading disclosures for Bausch Health Companies Inc

The latest disclosure was made by Seana Carson in Bausch Health Companies Inc where a trade of 16,973 Common Shares, No Par Value done at an average price of $7.4 was reported to US exchanges on Feb. 28, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Seana Carson EVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. 28 Feb 2025 16,973 590,617 (0%) 0% 7.4 126,279 Common Shares, No Par Value
Seana Carson EVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. 28 Feb 2025 5,994 607,590 (0%) 0% 7.4 44,595 Common Shares, No Par Value
Seana Carson EVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. 28 Feb 2025 26,325 564,292 (0%) 0% 7.4 195,858 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. 28 Feb 2025 85,100 1,880,160 (0%) 0% 7.4 633,144 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. 28 Feb 2025 96,911 1,783,249 (0%) 0% 7.4 721,018 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. 28 Feb 2025 24,838 1,965,260 (0%) 0% 7.4 184,795 Common Shares, No Par Value
John S. Barresi SVP, Controller & CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. 28 Feb 2025 2,865 197,364 (0%) 0% 7.4 21,316 Common Shares, No Par Value
John S. Barresi SVP, Controller & CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. 28 Feb 2025 5,096 192,268 (0%) 0% 7.4 37,914 Common Shares, No Par Value
Aimee J. Lenar EVP, US Pharma Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 108,311 252,663 (0%) 0% 0 Common Shares, No Par Value
John S. Barresi SVP, Controller & CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 49,823 200,229 (0%) 0% 0 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 635,425 1,990,098 (0%) 0% 0 Common Shares, No Par Value
Jean-Jacques Charhon EVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 216,622 515,460 (0%) 0% 0 Common Shares, No Par Value
Seana Carson EVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 180,518 613,584 (0%) 0% 0 Common Shares, No Par Value
Brett M. Icahn Director Grant, award, or other acquisition of securities at price $ 8.06 per share. 31 Dec 2024 4,109 156,780 (0%) 0% 8.1 33,119 Common Shares, No Par Value
John Paulson A. Director Grant, award, or other acquisition of securities at price $ 8.06 per share. 31 Dec 2024 7,754 268,049 (0%) 0% 8.1 62,497 Common Shares, No Par Value
B. Amy Wechsler Director Grant, award, or other acquisition of securities at price $ 8.06 per share. 31 Dec 2024 852 207,946 (0%) 0% 8.1 6,867 Common Shares, No Par Value
Seana Carson EVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. 29 Nov 2024 1,692 433,506 (0%) 0% 8.4 14,162 Common Shares, No Par Value
Carson Seana EVP, General Counsel Sale of securities on an exchange or to another person at price $ 8.35 per share. 29 Nov 2024 440 433,066 (0%) 0% 8.4 3,674 Common Shares, No Par Value
John A. Paulson Director Grant, award, or other acquisition of securities at price $ 8.16 per share. 30 Sep 2024 7,659 260,295 (0%) 0% 8.2 62,497 Common Shares, No Par Value
Amy B. Wechsler Director Grant, award, or other acquisition of securities at price $ 8.16 per share. 30 Sep 2024 842 207,094 (0%) 0% 8.2 6,871 Common Shares, No Par Value
Brett M. Icahn Director Grant, award, or other acquisition of securities at price $ 8.16 per share. 30 Sep 2024 4,059 152,671 (0%) 0% 8.2 33,121 Common Shares, No Par Value
Seana Carson EVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.19 per share. 05 Sep 2024 51,337 448,568 (0%) 0% 6.2 317,776 Common Shares, No Par Value
Seana Carson EVP, General Counsel Sale of securities on an exchange or to another person at price $ 6.21 per share. 05 Sep 2024 13,370 435,198 (0%) 0% 6.2 83,028 Common Shares, No Par Value
John S. Barresi SVP, Controller & CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.19 per share. 05 Sep 2024 3,982 150,406 (0%) 0% 6.2 24,649 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. 30 Aug 2024 14,683 1,354,673 (0%) 0% 5.9 87,070 Common Shares, No Par Value
Jean-Jacques Charhon EVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2024 298,838 298,838 (0%) 0% 0 Common Shares, No Par Value
John S. Barresi SVP, Controller & CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2024 49,254 154,388 (0%) 0% 0 Common Shares, No Par Value
Aimee J. Lenar EVP, US Pharma Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2024 144,352 144,352 (0%) 0% 0 Common Shares, No Par Value
John A. Paulson Director Grant, award, or other acquisition of securities at price $ 6.97 per share. 28 Jun 2024 8,967 252,636 (0%) 0% 7.0 62,500 Common Shares, No Par Value
Amy B. Wechsler Director Grant, award, or other acquisition of securities at price $ 6.97 per share. 28 Jun 2024 986 206,252 (0%) 0% 7.0 6,872 Common Shares, No Par Value
Brett M. Icahn Director Grant, award, or other acquisition of securities at price $ 6.97 per share. 28 Jun 2024 4,752 148,612 (0%) 0% 7.0 33,121 Common Shares, No Par Value
John S. Barresi SVP, Controller & CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.73 per share. 20 Jun 2024 1,930 105,134 (0%) 0% 6.7 12,989 Common Shares, No Par Value
Steven D. Miller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 35,360 174,877 (0%) 0% 0 Common Shares, No Par Value
Frank D. Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 35,360 35,360 (0%) 0% 0 Common Shares, No Par Value
John A. Paulson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 35,360 243,669 (0%) 0% 0 Common Shares, No Par Value
Amy B. Wechsler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 35,360 205,266 (0%) 0% 0 Common Shares, No Par Value
Sarah B. Kavanagh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 35,360 182,012 (0%) 0% 0 Common Shares, No Par Value
Christian A. Garcia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 35,360 35,360 (0%) 0% 0 Common Shares, No Par Value
Brett M. Icahn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 35,360 143,860 (0%) 0% 0 Common Shares, No Par Value
Richard C. Mulligan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 35,360 101,269 (0%) 0% 0 Common Shares, No Par Value
Robert N. Power Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 35,360 200,376 (0%) 0% 0 Common Shares, No Par Value
John A. Paulson Director Grant, award, or other acquisition of securities at price $ 10.61 per share. 29 Mar 2024 5,890 208,309 (0%) 0% 10.6 62,493 Common Shares, No Par Value
Amy B. Wechsler Director Grant, award, or other acquisition of securities at price $ 10.61 per share. 29 Mar 2024 647 169,906 (0%) 0% 10.6 6,865 Common Shares, No Par Value
Russel C. Robertson Director Grant, award, or other acquisition of securities at price $ 10.61 per share. 29 Mar 2024 2,945 225,279 (0%) 0% 10.6 31,246 Common Shares, No Par Value
Brett M. Icahn Director Grant, award, or other acquisition of securities at price $ 10.61 per share. 29 Mar 2024 3,122 108,500 (0%) 0% 10.6 33,124 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. 29 Feb 2024 23,871 1,457,159 (0%) 0% 9.9 236,084 Common Shares, No Par Value
Seana Carson EVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Feb 2024 147,536 530,461 (0%) 0% 0 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. 29 Feb 2024 2,895 1,483,443 (0%) 0% 9.9 28,632 Common Shares, No Par Value
Seana Carson EVP, General Counsel Sale of securities on an exchange or to another person at price $ 9.80 per share. 29 Feb 2024 1,561 500,038 (0%) 0% 9.8 15,298 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. 29 Feb 2024 2,413 1,481,030 (0%) 0% 9.9 23,865 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. 29 Feb 2024 87,803 1,369,356 (0%) 0% 9.9 868,372 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Feb 2024 519,328 1,486,338 (0%) 0% 0 Common Shares, No Par Value
John S. Barresi SVP, Controller & CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Feb 2024 39,126 110,252 (0%) 0% 0 Common Shares, No Par Value
John S. Barresi SVP, Controller & CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. 29 Feb 2024 3,188 107,064 (0%) 0% 9.9 31,529 Common Shares, No Par Value
Seana Carson EVP, General Counsel Sale of securities on an exchange or to another person at price $ 9.80 per share. 29 Feb 2024 133 499,905 (0%) 0% 9.8 1,303 Common Shares, No Par Value
Seana Carson EVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. 29 Feb 2024 765 529,696 (0%) 0% 9.9 7,566 Common Shares, No Par Value
Seana Carson EVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. 29 Feb 2024 5,994 523,702 (0%) 0% 9.9 59,281 Common Shares, No Par Value
Seana Carson EVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. 29 Feb 2024 16,973 506,729 (0%) 0% 9.9 167,863 Common Shares, No Par Value
Seana Carson EVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. 29 Feb 2024 511 506,218 (0%) 0% 9.9 5,054 Common Shares, No Par Value
Seana Carson EVP, General Counsel Sale of securities on an exchange or to another person at price $ 9.80 per share. 29 Feb 2024 4,420 501,798 (0%) 0% 9.8 43,316 Common Shares, No Par Value
Seana Carson EVP, General Counsel Sale of securities on an exchange or to another person at price $ 9.80 per share. 29 Feb 2024 199 501,599 (0%) 0% 9.8 1,950 Common Shares, No Par Value
Thomas J. Appio Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Feb 2024 519,328 1,486,338 (0%) 0% 0 Common Shares, No Par Value
John S. Barresi SVP, Controller & CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Feb 2024 39,126 110,252 (0%) 0% 0 Common Shares, No Par Value
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters